The company BeNuren Woman SL and the gynecologist from Almería, Gabriel Fiol from the Alborán CMM Clinic in Almería presented the Spanish Association against Cancer in Almería conducting a new observational study on the effects of laser technology in the treatment of premature vulvovaginal atrophy secondary to breast cancer treatment.
BeNuren Woman (S.L.) is a company that began its journey in 2016 and is dedicated to searching in the world of technology, equipment that improves the intimate quality of women, to establish a method that helps them solve these pathologies, many of them caused by the age and the disconnection that a woman has with her intimate area.
Collaborate with great professionals in the world of gynecology and obstetrics to seek the well-being of women and solve problems that make it impossible for them to have a full and quality life.
BeNuren reached an agreement with three highly prestigious gynecologists, including Dr. Gabriel Fiol from the Alborán CMM Clinic in Almería. The project is a multicenter and multidisciplinary study that aims to evaluate the efficacy and safety of a new type of non-ablative treatment with Solid State Vaginal Laser (LASEmaR mini 1500 ™ -EUFOTON) for the regeneration of vaginal tissue.
Magdalena Cantero, president of the Spanish Association Against Cancer of Almería, thanked the promoters twice for their performance. On the one hand, “it is appreciated that they have the Spanish Association Against Cancer to publicize these studies that may allow, in the near future, that women who have suffered cancer can improve their quality of life and allow them to have a normal life, without affecting their self-esteem and their relationships.
On the other hand, Magdalena Cantero thanked the research work and the study that is being developed because he considers that “research is fundamental in this disease and it is of the utmost importance and necessity that it reaches all people with cancer, constituting, in this specific case, an advance in gynecological and health performance “
The method of the study consists of performing a group of patients who have overcome breast cancer and have symptoms of atrophy, a total of 4 treatments in about two months with a non-ablative laser.
The contribution of BeNuren and always with the collaboration and contribution of all the professionals who research and advance with them in this field of sexuality and intimate health of women, will improve the quality of life of this large group of women who have already suffered from cancer, and must constitute a priority objective and thus open treatment possibilities.
– .
